• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05D
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Urticaria (2278)
Event Date 03/29/2024
Event Type  Injury  
Manufacturer Narrative
The product of this event was not returned to the manufacturer and could not be analyzed; however, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and not similar event has been reported with this lot number globally so far.The physician determined, this event as "non-serious injury" and the cause of the urticaria may have been due to use of fresh frozen plasma, but causal relationship between urticaria and the use of the medical device cannot be denied.We consider this event as "serious injury" since it was a systemic urticaria and medications are being administered via iv as a treatment.Although fresh frozen plasma may be the cause of the urticaria, the causal relationship between the urticaria and the use of the medical device cannot be denied because it occurred during the use of the medical device.Urticaria is described as one of the adverse events in "e.Precautions" of ifu.We will continue to monitor the occurrence of similar events carefully.
 
Event Description
This incident occurred in japan.Plasmaflo op-d series is identical model to op-05w(a) marketed in us.Patient with multiple sclerosis received plasmaapheresis therapy using op-05d.Fresh frozen plasma was used for replacement fluid.After completion of plasmapheresis therapy on (b)(6) 2024, itchy urticaria was developed.The areas where the urticaria occurred were the face, neck, both hands, part of the upper arm, and the left groin.After administering 1 vial of d-chlorpheniramine maleate and 125mg of methylprednisolone sodium succinate via iv, the patient's condition gradually improved and recovered within the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
2111-2
oaza sato
oita-shi, oita 870-0 396
JA   870-0396
Manufacturer Contact
naomi kagami
1-1-2
yurakucho
chiyoda-ku, tokyo 100-0-006
JA   100-0006
MDR Report Key19171046
MDR Text Key340899590
Report Number8010002-2023-00060
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberOP-05D
Device Lot NumberQN838J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/29/2024
Initial Date FDA Received04/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age41 YR
Patient SexFemale
Patient Weight68 KG
-
-